anti-Respiratory Syncytial Virus, Nucleoprotein antibody product blog
Tags: Antibody; Monoclonal Antibody; Respiratory Syncytial Virus, Nucleoprotein; anti-Respiratory Syncytial Virus, Nucleoprotein antibody;
The Respiratory Syncytial Virus, Nucleoprotein n/a (Catalog #MBS633075) is an Antibody produced from Mouse and is intended for research purposes only. The product is available for immediate purchase. The Mouse anti-Respiratory Syncytial Virus, Nucleoprotein (RSV) Monoclonal Antibody reacts with Bovine, Human and may cross-react with other species as described in the data sheet. MyBioSource\'s Respiratory Syncytial Virus, Nucleoprotein can be used in a range of immunoassay formats including, but not limited to, ELISA (EL/EIA), Immunohistochemistry (IHC).Suitable for use in Immunohistochemistry and ELISA.
Dilution: Immunohistochemistry(frozen): 1:100
Optimal dilutions to be determined by the researcher. Researchers should empirically determine the suitability of the Respiratory Syncytial Virus, Nucleoprotein n/a for an application not listed in the data sheet. Researchers commonly develop new applications and it is an integral, important part of the investigative research process.
To buy or view more detailed product information and pricing, please click on the technical datasheet page below:
Immunogen: Bovine RSV (strains 127, SNK and 9007). Human RSV strains A2, Long, Randall and 8/60. Hybridoma: NS1 myeloma cells with spleen cells from Balb/c mice. In general, we may offer more than one antibody to a given target to enable options for the researcher. Available antibodies recognizing Respiratory Syncytial Virus, Nucleoprotein are readily searchable from our website. Different antibodies against the same target such as Respiratory Syncytial Virus, Nucleoprotein may be optimized or tested for different applications and species. This enables researchers to select the option that may be best for their model system, to screen more than antibody to determine which one may be best for their model system, as well as to use more than one antibody to follow up on and validate their results.